Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,084,437
-$2,381,942 QoQ
Shares Held
1,808,599
-5.0% QoQ
Ownership
0.629%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. TSHA ranks #104 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,084,437 1,808,599
2025-12-31 $10,466,379 1,902,978
2025-09-30 $6,038,087 1,846,510
2025-06-30 $1,135,847 491,709
2025-03-31 $760,507 547,128
2024-12-31 $820,464 474,257
2024-09-30 $930,362 462,867
2024-06-30 $962,626 429,744
2024-03-31 $147,695 51,462
2023-12-31 $28,567 16,140
2023-09-30 $51,002 16,140
2023-06-30 $10,668 16,140
2023-03-31 $12,879 16,140
2022-12-31 $36,476 16,140
2022-09-30 $31,150 16,140
2022-06-30 $337,444 90,711
2022-03-31 $1,078,049 165,345
2021-12-31 $1,893,824 162,560
2021-09-30 $2,949,538 158,407
2021-06-30 $1,845,036 87,030
2021-03-31 $1,182,332 58,243
2020-12-31 $1,386,237 52,232